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Abstract 
Background: Pseudomonas aeruginosa (P. aeruginosa) is one of the leading causes of hospital acquired infections. 
Infections with P. aeruginosa are often hard to treat because of existence of different mechanisms of antibiotic 
resistance changes in permeability of drugs and activity multidrug efflux pumps. The aim of current study was to 
determine the antibiotic resistance pattern of P. aeruginosa and existence of efflux pump MexAB genes using PCR 
technique. Materials and Methods: 506 isolates cultured from different clinical specimens of patients hospitalized 
at Nohom Dey and Razi hospitals of Torbat Heydarie (northeast Iran) were collected and used in this study. Isolates 
were identified using conventional bacteriology and their susceptibility to different antibiotics were assessed using 
agar disk diffusion method. The PCR assay was used to detect efflux pump MexAB genes. Results: From 506 
isolates, 50 were identified as P. aeruginosa and these were isolated from isolated from blood, tracheal, burn, and 
wound. Incidence of P. aeruginosa was greater in males than females, wound infections had the highest number of 
occurrence and patients between 30-50 years were the most infected age group. In total, 60.86% of strains were 
multidrug resistant (MDR). The PCR technique revealed that most of the P. aeruginosa isolates and all the MDR 
strains contained MexA and MexB genes. Conclusion: The emergence of MDR microorganisms poses serious 
therapeutic problems for patients. Determining bacterial resistance mechanisms is complex. In this way, efflux 
systems were responsible for antibiotic resistance and played an important role in the MDR phenotype among P. 
aeruginosa isolates. 
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Multidrug resistance (MDR) in bacteria, 
including Pseudonomas aeruginosa, has been related 
to intrinsic drug resistance, mutations, low 
permeability of outer membrane, horizontal gene 
transfer of plasmids, transposons, bacteriophages and 
active efflux pumps (1-5). P. aeruginosa is a gram-
negative bacterium and opportunistic human 
pathogen which is associated with burn wounds and 
lung infections in patients with cystic fibrosis (3,6,7). 
The emergence of high prevalence nosocomial 
infections produced by P. aeruginosa has resulted in 
major therapeutic challenges to treatment, and is a 
cause of morbidity and mortality worldwide (8,9). The 
basic antibiotics used to treat P. aeruginosa infections 
are quinolones, cephalosporins, aminoglycosides and 
polymyxins (5,10). However, the emergence of drug 
resistant P. aeruginosa become a challenging public 
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health problem worldwide (10). Efflux pumps play a 
significant role in antibiotic resistance and were 
firstly described as an important component of 
resistance to tetracycline in Escherichia coli (10,11). 
Efflux pumps in bacteria have been categorized into 
five types (10). The efflux pump MexA-MexB-OprM 
is able to remove various dyes, detergents, and drugs 
including tetracyclines, β-lactams, fluoroquinolones, 
macrolides, novobiocin, sulfonamides, and 
trimethoprim (3,4,9). The MexAB-OprM genes, 
encoded MexAB-OprM pump, consist of inner 
membrane-associated complexes, MexA and MexB, 
and OprM, an outer membrane component. MexAB-
OprM production may lead to MDR in P. aeruginosa 
isolates (12). The aim of the current study was to 
determine the MDR rate in P. aeruginosa isolated 
from cases of infections referred to hospitals in 
Torbat Heydarie, and to investigate the existence of 
efflux pump MexAB genes as a possible mechanism 
of resistance using PCR. 
Methods 
Sample collection. This study was carried out 
over a period of one year. Totally, 506 different 
clinical, referred to Nohom Dey and Razi hospitals in 
Torbat Heydarie were processed for bacterial culture 
(Table 1). Patients’ data such as gender and age were 
recorded for all cases. This study was in accordance 
with the guidelines in the Declaration of Helsinki for 
the ethical treatment of human subjects 
P. aeruginosa isolation. Specimens were 
inoculated on Nutrient agar (Merck, Germany) and 
incubated at 37°C for 24 hours. The bacterial 
colonies were examined the morphology, and 
discrete colonies sub-cultured to obtain pure cultures. 
Isolates were identified as P. aeruginosa using 
standard biochemical tests (13). P. aeruginosa PTCC 
1394 was served as control strain in the experiments. 
Drug susceptibility testing. Antibiotic 
resistance patterns of P. aeruginosa isolates were 
determined using disk diffusion method on Mueller–
Hinton agar according to the CLSI guidelines 
(14,15). The following antibiotics were used in the 
assay: amikacin (30μg), ceftriaxone (30μg), 
ciprofloxacin (5μg), gentamicin (10μg), imipenem 
(10μg), norfloxacin (10μg), and tetracycline (30μg), 
(Mast, UK).   
DNA extraction and PCR. A single colony, 
identified as P. aeruginosa, was inoculated on 5 mL of 
brain heart infusion broth and incubated over night at 
37ºC, then total genomic DNA extraction of isolates 
was performed by boiling method (16). To confirm the 
presence of MexA and MexB genes PCR 
amplification was performed with a set of primer 
pairs. The primers used to target the genes were MexA 
(F) CTCGACCCGATCTACGTC, MexA(R) 
GTCTTCACCTCGACACCC, MexB (F) 
TGTCGAAGTTTTTCATTGAG and MexB(R) 
AAGGTCACGGTGATGGT. These primers amplified 
a specific fragment length of 503bp for MexA gene 
and 280bp of MexB gene. PCR was carried out in a 
total volume of 20μL and consisted of 10 pM of 
genomic DNA, 10 pM of each primer, and5μL of PCR 
Master Mix (Takapouzist, Iran). The amplification 
program was as follows: initial denaturation at 95°C 
(3m), then 35 cycles of denaturation at 94°C (1m), 
annealing at 58°C (1m), extension at 72°C (1m), and 
then a final extension at 72°C (7m). The amplified 
PCR products and 100-bp DNA ladder as the size 
marker (Kiagen, Iran) were separated by agarose gel 
electrophoresis on 1.5% agarose followed by staining 
with ethidium bromide (Qiagen, Germany). After 
electrophoresis results were visualized using the gel 
documentation system (Protein Simple, USA).   
Statistical analysis. SPSS software (SPSS Inc 
no. 17) was used to analyze the relationship between 
the resistance to antibiotics and presence of genes. 
Results 
Bacterial isolates. Five hundred and six swab 
samples were collected from blood (14%), tracheal 
(30%), wound (38%), and burn infections (18%). Of 
the 506 clinical cultures, 50 (9.88%) were positive for 
P. aeruginosa. The prevalence and total distribution of 
P. aeruginosa recovered from various types of 
infections is given in Table 1. The prevalence of P. 
aeruginosa in study population were at the highest 
levels in men (66%), patients between 30-50 years 
(56%) and specimens from cases with wound 
infections (38%). Significant differences (P<0.05) 
were found in the prevalence rates of P. aeruginosa 
between age groups, male and female cases and type 
of infections. 
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Antibiotic resistance profile. Table 2 shows 
the results of antibiotic resistance patterns of P. 
aeruginosa strains to seven selected antibiotics. 
Isolates showed the highest levels of resistance to 
tetracycline (86.95%) followed by ceftriyaxon 
(82.61%), amikacin (43.47%), ciprofloxacin, 
norfloxacin, and gentamicin (39.13%). The lowest 
rate of resistance was against imipenem (34. 78%). 
Only 4.34 % of the isolates were susceptible to seven 
antibiotics. According to criteria defined for MDR 
(17,18), 60.86% of P. aeruginosa isolates were 
determined as MDR, which exhibited resistance to 
four of seven antibiotics and 30.43% of isolates were 
showed resistance all seven antibiotics. The MDR 
strains were isolated from blood, tracheal and wound 
infections. One strain was from a burn infection and 
showed no resistance to any antibiotics. 
Presence of MexA-MexB. The presence of 
efflux pump MexA and MexB genes was found in 43 
(86.95%) and 41 (82.60%) of isolates respectively. 
Only in 8 isolates lacked MexB gene. The results were 
correlated with high rates of resistance to tetracyclin 
(> 80%), ceftriaxon (> 80%), amikacin (> 40%), and 
quinolones and aminoglycosides (> 35%), suggesting 
a possible role for MexAB genes. According to the 
PCR results, all MDR strains recognized by 
susceptibility techniques (60.86%), contained MexA 
and MexB genes (Figs. 1 &2). 
 
Discussion 
P. aeruginosa is one of the important pathogens 
leading a broad-spectrum of nosocomial infections 
worldwide (8,18). In this study, 50 samples (9.88%) 
were positive for P. aeruginosa out of 506 samples 
collected from Nohom Dey and Razi hospitals in 
Torbat Heydarie city. Siguan et al. have been reported 
low prevalence of P. aeruginosa (18.8%) in human 
 
Table 1. Total distribution of P. aeruginosa in the swab 
samples taken from various types of infections 
Different Criteria No. of 
Samples 
P. aeruginosa 
Type of infection   
Wound 167 19 
Burn 93 9 
Tracheal 181 15 
Blood 65 7 
Gender   
Male 257 33 
Female 249 17 
Age group, y   
< 10 22 2 
10-30 80 5 
30-50 197 28 
50-70 189 13 
> 70 18 2 
Total 506 50 
 
 
Table 2. Antibiotic resistance patterns of P. aeruginosa 








43.47 21.73 34.80 Amikacin 
82.61 17.39 0 Ceftriaxon 
39.13 0 60.87 Ciprofloxacin 
39.13 4.35 56.52 Gentamicin 
34.78 4.35 60.87 Imipenem 
39.13 0 60.87 Norfloxacin 




Figure 1. Results of PCR amplification of MexA gene (503 bp) of 




Figure 2. Results of PCR amplification of MexB gene (280 bp) of 
Pseudomonas aeruginosa, c-: negative control, c+: positive control, Ladder 
100bp. 
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infections previously (19). In other investigations, 
prevalence rate of P. aeruginosa has been shown 
27.7% by Ranjan et al.(20), 32% by  Bhattacharjee et 
al.(21), 27.78% by Masaadeh and Jaran (22) and 
62.6%  by Khosravi et al.(10), which were higher 
compared to our findings. The main cause of this 
disagreement is that the samples of current study 
were not entirely taken from burn wounds.Moreover, 
low prevalence rate of P. aeruginosa (9.88%) in the 
clinical samples of this study may be due to health 
care quality is different with those of other studies. 
The results of the present study showed that, the 
highest rates of isolates of P. aeruginosa were found 
in wounds (38%), followed by tracheal (30%), burns 
(18%), and blood (14%) infections. Javiya et al. 
reported the highest number of P. aeruginosa isolates 
from urine infections (23) and in another study by 
Manjunath et al., 37.17% of isolates were obtained 
from wound specimens which is similar to our results 
(13). P. aeruginosa remains a common cause of 
wound infection especially in burns wounds because 
burns have large exposed area of dead tissue and no 
defense against microbial infections (13). We 
reported a higher prevalence of P. aeruginosa in men 
than women, which is same as Al-Hasan et al.(24) 
and Khan et al.(25). High prevalence in women were 
also reported by Mulu et al.(26) and Okon et al.(27). 
Our results showed that  the highest rates of isolation 
were in the age group of 30–50 years, that was 
similar to Manjunath et al. (13). In another 
investigation, Rajat et al. showed 29% isolation rate 
in the age group of 31–45 years (28) which is partly 
in line with  our finding. Chander Anil and Raza also 
reported 20% isolation rate in age group of 21–40 
years (29). This may be due to prolonged 
hospitalization, prolonged antibiotic therapy and 
decreased immunity. The results is contrast with a 
another report in which a high prevalence of P. 
aeruginosa in old patients (30), and in children was 
reported (31). 
Prevalence of MDR bacteria and effectiveness 
of several antipseudomonal drugs make the use of 
antibiotics to treat infectious diseases a serious 
problem, especially for the human pathogen P. 
aeruginosa with its ability to adapt to antibiotics and 
emerging a multidrug-resistant phenotype (9). This 
study focused mainly on screening the antibiotic 
resistance patterns of P. aeruginosa isolates and used 
anti-pseududomonal drugs. According to the disk 
diffusion method, we found high levels of resistance to 
all antibiotics with the prevalence of MDR among P. 
aeruginosa isolates from Nohom Dey and Razi 
hospital in Torbat Heydarie. The majority of the 
published studies, have reported that MDR isolates 
exhibited resistance against at least three types of anti-
pseudomonas drugs from a variety of antibiotic classes 
(10). According to our results, 60.86% of P. 
aeruginosa isolates were defined as MDR, the most 
and least effective antibiotics against the bacteria were 
imipenem (60.87%) and ceftriaxon (0%) respectively. 
The rate of resistance of P. aeruginosa isolates against 
ceftriaxon, ciprofloxacin and norfloxacin were 
82.61%, 39.13% and 39.13% respectively. Delpano et 
al. reported higher levels of antimicrobial resistance 
compared to the present study. Their results showed 
100% resistance to gentamicin, meropenem, 
imipenem, and ciprofloxacin, and 83% - 94% to other 
tested antibiotics (10). In a study in Nepal, the rate of 
resistance against ceftriaxone and ciprofloxacin was 
50%, and 100%; there was no resistance against 
gentamicin and ampicillin (32). Similar results were 
also reported from Pakistan (33) but, Krishnakumar et 
al. found 50% ampicillin resistance in India (34). 
Indian studies showed the prevalence of resistance 
against gentamicin among isolates as 63%. High levels 
of resistance to gentamicin have also been documented 
from Iran and Pakistan(27,35-37). These results are in 
contrast with a previous study by Ahmed et al. that 
found 43.9% gentamicin resistance in clinical samples 
in Egypt (38). According to these reports, our isolates 
were less resistant to gentamicin (39.13%). In the 
present study, amikacin resistance rate was estimated 
as 43.47% which is higher than other resistance 
results, reported in Russia (25%), USA (13.1%), 
France (9%) Spain (9%), and Turkey (4%) (39). High 
rate of resistance to tetracycline (100%) has also been 
reported from Egypt (38). In the current study, 86.95% 
of isolates were resistant to tetracycline. Many studies 
have focused on the resistance patterns of P. 
aeruginosa isolates to carbapenems, which are still as 
a therapeutic choice for nosocomial infection caused 
by P. aeruginosa (10). Resistance of P. aeruginosa to 
imipenem, the most effective antibiotic at Torbat 
Heidaryeh hospital (34.78%) is an emerging problem 
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in that area. Khosraviet al. reported prevalence of 
MDR isolates about 41% in Ahwaz with 38% of 
them being resistant to  carbapenems (40), which is 
similar to our results. 
Recent studies have shown that efflux pumps 
play a significant role in bacterial drug resistance 
(6,10,18). Since MexAB-OprM efflux pump is 
mediated  in resistance to many important antibiotics, 
including fluoroquinolones, tetracyclines and B-
lactams (9,10), we investigated the presence of  en-
coding genes of this pump. Genotyping investigation 
was performed using PCR for the existence of efflux 
pump MexAB genes and showed that 43P. 
aeruginosa isolates had the MexA gene and 41 
isolates had MexB gene. Auda Al-Grawi et al. 
obtained similar results (39). Because of the possible 
role of this efflux pump in drug resistance, more than 
40% of all tested isolates were estimated to be 
resistant to tetracyclin, ceftriaxon and amikacin. 
Similar to our findings, Khosravi et al. reported 
efflux MexAB genes were detected in all MDR P. 
aeruginosa strains (10). Expression of efflux pumps 
in MDR bacteria, that are capable of pumping out 
structurally different antimicrobial agents, 
contributes to reduced susceptibility against drugs.  
In this work, we investigated the presence of 
only one of the multiple mechanisms of drug 
resistance and confirm the presence of the MexAB 
efflux genes in P. aeruginosa isolates, which cannot 
reveal the existence a functional MexAB efflux 
pump and its mediation in resistance. This is 
preliminary study to analyse the genetics of efflux 
pump-mediated drug resistance in P. aeruginosa. 
More investigations are required to prove whether 
these genes are functional and expressed. Though 
existence of the MexAB efflux genes is a possible 
reason for multi-drug resistance in this bacterium, it 
is necessary to use the efflux pump inhibitors to 
identify the association between presence of these 
genes and antibiotic resistance. 
Conclusion 
Imprudent use of broad-spectrum antibiotics 
may cause high rates of resistance in P. aeruginosa 
strains in our investigation. The present study 
demonstrated an increasing rate of MDR P. aerugi-
nosa in wounds, tracheal and blood samples obtained 
from two university hospitals. A strategy should be 
designed and implemented to limit the MDR rate. 
Hence, the prudent use of antibiotics is needed. Also, 
because of the regional variation of drug resistance 
and susceptibility pattern in each hospital, it is 
important that each hospital using the local data on 
resistance pattern develops their own antimicrobial 
policy. In the present study, Efflux MexAB genes 
were detected in all MDR strains. Understanding the 
exact mechanisms involved in drug resistance can 
improve the strategies for the management and control 
of infection disease at the hospitals.  
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